Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

ONS: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for Nurses 

ONS: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for Nurses 


Date: May 17, 2018

Lunch: 11:30 AM
Scientific Session: 12:15 PM - 1:45 PM

Location:
Marriott Marquis
Marquis Ballroom 5
901 Massachusetts Avenue NW
Washington DC, 20001

Overview

This interactive and dynamic symposium will update oncology nurses on recent developments in therapy for patients with non–small cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor (EGFR) gene, from diagnosis through multiple lines of care. Changing treatment paradigms in first-line therapy for patients with EGFR-mutated NSCLC require a reassessment of the testing and treatment algorithm. These changes also impact the evaluation of disease progression and selection of subsequent lines of therapy. Throughout this process, it is essential to maximize the ratio of antitumor activity to adverse events. Given the key role of nurses in the multidisciplinary care team, it is essential that oncology nurses be familiar with best practices in molecular diagnostics, selection of therapy, and management of adverse events (AEs).

To meet this educational need, oncology nursing experts, along with their physician peers, will lead this cutting-edge Working Group to discuss best practices that attendees can apply in their clinical practice.

Key topics to be addressed by the expert faculty include:

  • Evolving approaches, including plasma-based testing, for lung cancer diagnosis in the era of precision medicine
  • New standards of care to optimize outcomes in the frontline management of patients with EGFR-mutated, advanced NSCLC, as well as to optimize subsequent lines of therapy
  • Proactive approaches to managing treatment-related AEs

This symposium will be held at the Marriott Marquis in Washington, DC, on May 17, 2018. Please join us to learn the most up-to-date approaches for managing patients with EGFR-mutated NSCLC.

You won’t want to miss this program!

Target Audience:

This educational program is directed toward all attendees of the ONS 43rd Annual Congress, including nurses and other healthcare professionals with an interest in the treatment of lung cancer.

Learning Objectives:

Upon completion of this activity, participants should be better prepared to:

  • Explain optimal testing platforms to utilize that can inform clinical decision making in newly diagnosed and relapsed patients with advanced NSCLC
  • Apply clinical trial evidence to optimize the initial treatment of advanced EGFR mutation‒positive NSCLC
  • Determine key resistance mutations and strategies to address relapsed disease, and to optimally sequence approaches beyond disease progression in advanced NSCLC
  • Describe practical methods to proactively identify and mitigate the impact of treatment-related toxicities in the management of patients with advanced NSCLC

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

Program Co-Chairs

Benjamin Levy, MD
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC
 

Rasheda Persinger, MSN, AGNP-BC
Medical Oncology Nurse Practitioner
Sibley Memorial Hospital
Washington, DC







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
262728293031
Filter By